FilingReader Intelligence
Sudarshan Pharma acquires plant for INR 25.50 crores
August 14, 2025 at 03:20 PM UTC•By FilingReader AI
Sudarshan Pharma Industries Limited will acquire land, building, and plant & machinery totaling 1,563.15 square meters in Telangana for INR 25.50 crores from Srigen Lifesciences Private Limited.
The acquisition, expected to complete by December 31, 2025, includes a plant with 80 kilolitres reactor capacity to expand production capabilities for pharmaceuticals and chemicals.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:SUDARSHAN•Bombay Stock Exchange
News Alerts
Get instant email alerts when SUDARSHAN PHARMA INDUSTRIES publishes news
Free account required • Unsubscribe anytime